Infiltrating Ductal Breast Carcinoma in a Male Patient With Associated BARD1 Mutation

Male breast cancer is an uncommon diagnosis with limited research on management and prognosis due to its rarity. We discuss a case of a 55-year-old male with a non-contributory past medical history who presented with an enlarging palpable mass of his right breast tissue at the 10:00 position. The ultrasound of the right breast showed a 2.8 cm heterogenous mass with irregular borders highly suspicious for malignancy. The follow-up sonogram-guided core biopsy was performed, and the pathology of the mass confirmed high-grade infiltrating ductal carcinoma. A modified radical mastectomy of the right breast with extensive axillary lymph node excision was performed. Genetic testing of the excised tumor revealed a MUTYH gene mutation and a BARD1 (BRCA1-associated RING domain 1) gene mutation of unknown significance. Histopathological analysis confirmed a Grade 2, ER/PR-positive, KI 67-positive, and HER2-negative tumor.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-08-05
DOI
https://doi.org/10.7759/cureus.66216
Primary Topic
Male Breast Health Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Infiltrating Ductal Breast Carcinoma in a Male Patient With Associated BARD1 Mutation

Nuria Lawson, Danielle Donahue, Mackenzie Fannin, Joseph McGrath et al.
Cureus
Male Breast Health Studies
article

Infiltrating Ductal Breast Carcinoma in a Male Patient With Associated BARD1 Mutation

Nuria Lawson, Danielle Donahue, Mackenzie Fannin, Joseph McGrath, Dillin J Rhatigan
article en

Abstract

Male breast cancer is an uncommon diagnosis with limited research on management and prognosis due to its rarity. We discuss a case of a 55-year-old male with a non-contributory past medical history who presented with an enlarging palpable mass of his right breast tissue at the 10:00 position. The ultrasound of the right breast showed a 2.8 cm heterogenous mass with irregular borders highly suspicious for malignancy. The follow-up sonogram-guided core biopsy was performed, and the pathology of the mass confirmed high-grade infiltrating ductal carcinoma. A modified radical mastectomy of the right breast with extensive axillary lymph node excision was performed. Genetic testing of the excised tumor revealed a MUTYH gene mutation and a BARD1 (BRCA1-associated RING domain 1) gene mutation of unknown significance. Histopathological analysis confirmed a Grade 2, ER/PR-positive, KI 67-positive, and HER2-negative tumor.

CureusVol. 16(8)
Nova Southeastern University (US), Palmetto General Hospital (US)
Good health and well-being
Openalex Percentile: Top 81%
Male Breast Health Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Infiltrating Ductal Breast Carcinoma in a Male Patient With Associated BARD1 Mutation — Nuria Lawson, Danielle Donahue, et al. · Cureus (2024) | TGRS Research Map | TGRS